Member Info for RMM3383

The one I'm looking at is US20190350905A1. I think its just a system glitch that changed the wording. Not getting excited.....yet!

Warthog - Good post. Patent Pending is not absolute protection but in this case it only applies to the new application. We're safe behind the original award.

Can't remember the exact wording before but it's now just one word 'Pending'. Would be nice to think that Trump's red tape cutting is taking effect already but I don't believe they'd move that quickly!!

Not sure why but the wording on the US Patent Office Status for TYK2 -Cancer has changed. Might be just a system glitch but its now simply showing 'Pending'. Nothing to get excited about yet but they've had this for over 4 months and a finding must be due shortly. Not expecting an RNS this week but a steady rise would be in order given the mounting optimism not to mention the need for the molecules. GLA

Bed and ISA asap. Having bought at 1.3p and transferring at a lower price (say 0.8p if the price doesn't spike tomorrow) isn't a problem because you'll have no capital gains tax to pay. What is important is to retain as much of your volume as possible. A good broker should get you a transfer with only a marginal loss in volume. All your growth is then tax free. Selling now and buying back in 3 days time could cost you a lot of money in terms of lost growth and volume. Book a transfer ASAP. All IMHO and not to be construed as advice on investing in SAR! Good luck!!

A thought crossed my mind during the night. If you had a product bringing in sales of $2bn but with significant side effects and someone developed an alternative with no side effects wouldn't you want to buy up the new entrant to protect your $2bn? Especially if the $2bn was to become $12bn+. Now add in the fact that you've struck a collaboration with another large pharma to tackle Covid 19. You've also signed a deal with a german biotech to develop a vaccine. Your biotech now works with you on all markets outside China while your collaborating Pharma get the Chinese market. All sounds very cosy. Now add in the names - Pfizer, Fosun and BioNTech. Big money,huge capability and looking to take a large share of the vaccine market for Covid 19. But also interested in immune oncology (Parp inhibitors in the case of Pfizer) and theraputics. Combo treatments now very much of the moment. I'd be very surprised if Pfizer and possibly Fosun weren't looking at SAR. With regard to Utah's comment on 'we'd never see $9bn'. I agree. I think if that looks a possibility then we'll be bought well in advance. 737 to Gilead and 1801/2 to Pfizer? Aurora to ?? Lots of good posts this weekend. Keep them up people. We're going into a formative period. All IMHO. GLA

Fearg - if we get near to £I I’ll be making a big donation to the NHS and other health related institutions. I’d like to make this life changing for a wide audience. GLA

Latest findings from the WHO are that getting and surviving the virus does not give you immunity. Until a generic vaccine is available the focus in the short term will be on therapeutics. TYK2 and FLT are all about therapeutics which means they have value now whilst the race develops for a vaccine. Even with a vaccine the therapeutic benefits for respiratory conditions including pneumonia are enormous. Furthermore a vaccine will not protect against mutations. The market for therapeutics will be large and long term. I await news.... as to a placing, not even sure why this is on the radar? They don’t need the cash at present and I strongly suspect upfront and milestones are top of their mind. GLA

Interesting that if you read the UKRI release its broader than just developing a vaccine. They talk about 'therapy development' but there's nothing there that talks to TYK2 or similar. I'd be surprised if we are involved...… because I think we're involved elsewhere. For info:
https://www.ukri.org/news/covid-19-research-boosted-by-new-projects/?_ga=2.170806688.1002714171.1587147376-1262639606.1581077290

Potnak - if they tried to split the deal the only people who would make money would be the lawyers. It would be messy and involve so many caveats as to be undoable. As I said yesterday, Covid has put a spanner in the works in the best possible way and now we need to let the game play out. I’m very happy with the rises this week considering we’ve had no news. Good to see us get back to where we should be. GLA.

Hi Aber - I've never had to wait more than a couple of hours for a reply from the Chairman. Tim and John are busy.... maybe you are right?

I'm hoping its more than just grant funding they are working on......

Hi Potnak - I agree the multi £ territory is heavily dependent on a major, major breakthrough..... but I'm not discounting it! Why haven't we been bought out? Because the rules of the game changed and we still need a few things to be resolved. In this respect timelines might actually shorten.

Hi Krone - Believe me, I've had my doubts in the past but this is no P&D. If we breach 0.85 today I'll be a happy man. Anything else is gravy.... until next week!

Having taken the night to think through all that has happened in the last few days I've surprised myself by realising how the focus of sentiment has changed. This time last year we were all eyes on 737 with milestones in sight. 12 months on and we have Aurora top of the agenda closely followed by TYK2 and 737 somewhere in the back office. Even with good rises over the last few days SAR is still only a £24m company. Getting to be a £500m company at 16p a share is by no means impossible. We haven't had any news and the absence of speeding tickets can only be positive. Getting to be a £1bn or more company might be a big ask but these are unprecedented times and we have an exceptional pipeline. Keep the faith people. GLA

N4 - good link. I think we can expect a rash of deals over the coming weeks. Hopefully SAR will be one of them.....

SOG - the patent application has been ‘status pending’ for over 4 months. Given the current environment it must be due a resolution very soon. Unless the ‘experts’ are in isolation....

N4 - Does that mean that if Sar come up trumps you'll be buying Newcastle??

N4 - I don't disagree if its a bidding war. However, its not unknown that one party signs a solus agreement, a price is set and terms agreed subject to contract and certain other criteria being met such as a patent application. An opportunity to raise the price comes up unexpectedly (and even if you're not a salesman the Covid value is blindingly obvious) and the vendor says that unless the buyer ups the price they will terminate the deal (because they've already been approached with a better deal). Negotiations then enter a completely new phase. I honestly believe they know the value of what they have and won't sell short. Negotiations will be complicated but the current situation could accelerate things dramatically.

My take FWIW:
Tim and John are in discussions but they have been complicated by Covid. No one expected this at the AGM and the focus was on getting the patent on TYK2 sorted with 737 to be resolved at some point in time but out of the BoDs hands. I still think the patent application is a major issue because with a new patent and timescale the value increases significantly. Now add in Covid. If this wasn't going to add value to a deal you wouldn't bother commenting on it. You want my products? Well, at the moment its this price. If we get the patent approved, its a higher price. If its a Covid 19 therapeutic the price just went up by a factor. I think the BoD are giving us a very clear message: We've got great products and we have people interested in them. A few weeks ago people were saying they'd be happy to get a deal worth 3p. That IMHO would be criminal. Hold tight everyone, we're in for one hell of a ride! GLA

Hi Thoth - its the same project that the BBC promoted earlier today. They're also asking 'small biotechs' for help. I'm pretty sure we're not involved because I think we are active 'elsewhere'.